Stay updated on GO-2 Study RVT-1401 in Graves' Ophthalmopathy Clinical Trial
Sign up to get notified when there's something new on the GO-2 Study RVT-1401 in Graves' Ophthalmopathy Clinical Trial page.

Latest updates to the GO-2 Study RVT-1401 in Graves' Ophthalmopathy Clinical Trial page
- Check3 days agoChange DetectedThe ClinicalTrials.gov page revision number changes from v3.8.0 to v3.8.1.SummaryDifference0.0%

- Check10 days agoChange DetectedThe page changes from a 403 error screen to the ClinicalTrials.gov record for the ASCEND GO-2 study, displaying its study details and results information.SummaryDifference59%

- Check17 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.2 to v3.8.0, while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check31 days agoChange DetectedAn NIH-wide banner announces a transition from “Artificial Intelligence” to “Super Intelligence” terminology. The page continues to show a 403 error instead of the study record.SummaryDifference1%

- Check45 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check52 days agoChange DetectedAccess to the study record now results in a 403 Forbidden error, replacing the usual page content with a generic error message. The error page includes a Home link, indicating the study page is currently inaccessible rather than presenting the study details.SummaryDifference0.5%

Stay in the know with updates to GO-2 Study RVT-1401 in Graves' Ophthalmopathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GO-2 Study RVT-1401 in Graves' Ophthalmopathy Clinical Trial page.